Coexistence of Positive 99m Tc-DPD Scintigraphy and Monoclonal Gammopathy: A Frequent Challenge

• Published in: Acta Cardiologica Sinica 2022-03, Vol.38 (2), p.169
• Main Authors: Roteta Unceta-Barrenechea, Ana, Melero Polo, Jorge, Andrés Gracia, Alejandro, Revilla Martí, Pablo, Menao Guillén, Sebastian, Lahuerta Pueyo, Carmen, Pérez-Palacios, Raquel, Moreno Gázquez, Inmaculada, Gutiérrez, Anyuli Gracia, Aibar Arregui, Miguel Ángel
• Format: Article
• Language: English
• ISSN: 1011-6842

Cardiac involvement is common in amyloidosis, and the vast majority of cases of amyloid cardiomyopathy are attributed to primary amyloidosis or transthyretin amyloidosis (ATTR). Although the coexistence of scintigraphy suggestive of ATTR with monoclonal gammopathy of undetermined significance is well documented, the correct diagnosis is still challenging in non-referral centers. We performed a retrospective study reviewing all amyloid cardiomyopathy cases diagnosed at our center over the last 5 years, and described our experience and diagnostic approach. During the last 5 years, 74 patients with positive scintigraphy were identified. Of these patients, 41 were included in this study as they had all necessary tests for a complete diagnosis. Two of these 41 patients had variant ATTR and 29 had wild-type ATTR. Ten patients had monoclonal gammopathy (24.4%), and it was consequently impossible to obtain a specific diagnosis. During follow-up, 14 patients (34.1%), five of them from the monoclonal gammopathy group, died, reflecting the severity of disease. In patients with ATTR-suggestive scintigraphy, monoclonal gammopathy frequently occurs concomitantly, thus not allowing to establish a specific diagnosis. A biopsy could only be replaced by genetic testing in selected cases.